Biotech News
T2 Biosystems Announces Third Quarter 2024 Financial Results
investors.t2biosystems.com2026-05-06 15:23 EST
Achieved 34% quarterly revenue growth compared to the prior year period LEXINGTON, Mass. , Nov. 14, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems , Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced financial and